Table 3.
Persistent Organic Pollutants and the Gut Microbiome
Chemical | Exposure Window | Dose | Model | Sex & Sex Differences | Effect on Gut Microbiota | Conclusions | References |
---|---|---|---|---|---|---|---|
PCB mixture | Developmental | 0, 0.1, 1, or 6 mg/kg/day starting 2 weeks before gestation and continuing through PND 21 |
|
No sex effects were observed, so all the data are combined and represented as equal proportions of males and females |
|
|
Rude et al. (2019) |
PCB-126 | Adult, 7 weeks old | 0 or 1 µmol/kg/day at weeks 2 and 4 | Ldlr−/− mice | Male |
|
|
Petriello et al. (2018) |
Atrazine, estradiol, PCB126, PCB153 | Adult (4 months) | DMSO or 1.0 µg/l of environmental pollutant mixture | Zebrafish |
|
↑ Aeromonas in females |
|
Chen et al. (2018b) |
PCB congeners (PCB153, PCB138, PCB180) | Adults 11–13 months of age | Exercise for 5 days followed by 2 days of oral exposure to PCB mixture (150 µmol/kg) | C57Bl/6J mice | Males |
|
|
Choi et al. (2013) |
PAH parent compounds: naphthalene, phenanthrene, pyrene, and benzo(a)pyrene | In vitro | 62.5 nmol | In vitro SHIME | Not applicable | Not specified |
|
Van de Wiele et al. (2005) |
PAH | Information not available | No exposure to oil (northern Norway area) or 0.01 ppm exposure to oil (southern Norway area) | Atlantic cod (Gadus Morhua) | Not applicable | Clean water fish: Fusobacteria and Proteobacteria were the most abundant, followed by Firmicutes and Bacteroidetes. Fish exposed to oil-contaminated waters showed dominance in Firmicutes, followed by Proteobacteria, Bacteroidetes, and Fusobacteria. Vibrionales was the most abundant order identified |
|
Walter et al. (2019) |
PFBS | In utero exposure (eggs exposed to PFBS) | 0, 1.0, 2.9, 9.5 µg/l for the entire lifecycle | Marine medaka |
|
Intestines of F0-exposed males:
|
|
Chen et al. (2018a) |
PFAS: F-53B | Adult, 6 weeks old | 0, 1, 3, or 10 µg/l for 10 weeks | C57Bl/6 mice |
|
|
|
Pan et al. (2019) |
BDE-47 | In utero and lactational exposure | 0, 0.002, and 0.2 mg/kg BDE-47 from GD 6 to PND 21. Male mice selected to be either on normal diet or HFD for 14 weeks | Primigravida female ICR mice | Only male mice were selected for analysis |
|
|
Wang et al. (2018a) |
BDE-47 or BDE-99 | Adult, 9 weeks old | 0 or 100 µmol/kg/day for 4 days | C57Bl/6 mice (conventional and germ-free) | Males | PBDE exposure altered 23 gut microbial taxa |
|
Scoville et al. (2019) |
OBS | Adult, 6 weeks old | 0, 0.1, 1, or 10 µg/l | ICR mice | Males | Not applicable |
|
Wang et al. (2019b) |
HCH | Adult | N/A | Mothers-humans | Males and females were combined for analyses, so sex differences were not determined |
|
|
Tang et al. (2019) |
Endosulfan | Adult, 8 weeks old | 0, 0.5, or 3.5 mg/kg/day for 2 weeks | ICR mice | Male | Not applicable |
|
Zhang et al. (2017) |
TCDD | Juvenile, 4 weeks old | 0 or 30 µg/kg/day every 4 days for 28 days | Gnotobiotic C57Bl/6 | Female | ↑ Segmented filamentous bacteria (SFB)↓ Bacteroides fragilis |
|
Stedtfeld et al. (2017b) |
TCDD | Juvenile, PND 28, 29 | 0–30 µg/kg/day for 28 and 92 days with the latter having a 30-day recovery period | C57Bl/6 mice | Female | ↑ Enterobacteriaceae |
|
Stedtfeld et al. (2017c) |
TCDD | Adult, 5–8 weeks old | 0, 0.1, 1.0, and 10 µg/kg/day for 4 days | B6C3F1 mice | Female | Expression of SFB in mouse ileum |
|
Stedtfeld et al. (2017a) |
TCDD | Adult, 6 and 7 weeks old | 0 or 6 µg/kg biweekly for 26 weeks | CD-1 mice in a prediabetic hyperglycemic state via streptozotocin intraperitoneal injection | Male |
|
|
Lefever et al. (2016) |
TCDD, PhIP, HBD, B[a]P, deltamethrin, and PAHs | Adults | 0.005, 0.90, 2.60, 5, 21, and 38 µg/ml |
|
Not applicable | Not applicable |
|
Defois et al. (2018) |
TCDF | Adult (8 weeks old) | 0 or 24 µg/kg/day for 5 days | C57Bl/6J mice | Males |
|
|
Zhang et al. (2015a) |
Abbreviations: α-HBCD, α-hexabromocyclododecane; γ-HBCD, γ-hexabromocyclododecane; BDE-47, 2,2′,4,4′-tratrabromodiphenyl ether; DMSO, dimethyl sulfoxide; F-53B, 6:2 chlorinated polyfluorinated ether sulfonate; FXR, farnesoid X receptor; HCH, hexachlorocyclohexane; OBS, sodium p-perfluorous nonenoxybenzene sulfonate; PAH, polycyclic aromatic hydrocarbons; PBDE, polybrominated diphenyl ether; PCB, polychlorinated biphenyls; PFAS, per- and polyfluoroalkylated substances; PFBS, perfluorobutane sulfonate; SCFA, short-chain fatty acid; SHIME, Simulator of the Human Intestinal Microbial Ecosystem; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TCDF, 2,3,7,8-tetrachloro dibenzofuran.